Helix BioPharma (TSX:HBP) 3-Year FCF Growth Rate : 30.10% (As of Jan. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma 3-Year FCF Growth Rate?

Helix BioPharma's Free Cash Flow per Share for the three months ended in Jan. 2024 was C$-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 30.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 14.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Helix BioPharma was 30.10% per year. The lowest was -7.90% per year. And the median was 6.10% per year.

Competitive Comparison of Helix BioPharma's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Helix BioPharma's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's 3-Year FCF Growth Rate falls into.

Helix BioPharma 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Helix BioPharma (TSX:HBP) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Helix BioPharma 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma (TSX:HBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

HBPCF:USA

Address

401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.